From FLOW to translational positioning in chronic kidney disease: mechanistic complementarity of SGLT2 inhibitors and GLP-1 receptor agonists.
- DOI
- 10.1016/j.trsl.2026.07.008
- Published
- 2026 Oct
- Container
- Translational research : the journal of laboratory and clinical medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.trsl.2026.07.008,
title = {From FLOW to translational positioning in chronic kidney disease: mechanistic complementarity of SGLT2 inhibitors and GLP-1 receptor agonists.},
author = {Tian X and Ma X and Song E and Li X and Fu W and He H and Gao Z and Gao B},
year = {2026},
journal = {Translational research : the journal of laboratory and clinical medicine},
doi = {10.1016/j.trsl.2026.07.008},
url = {https://doi.org/10.1016/j.trsl.2026.07.008}
}RIS
TY - JOUR TI - From FLOW to translational positioning in chronic kidney disease: mechanistic complementarity of SGLT2 inhibitors and GLP-1 receptor agonists. AU - Tian X AU - Ma X AU - Song E AU - Li X AU - Fu W AU - He H AU - Gao Z AU - Gao B PY - 2026 JO - Translational research : the journal of laboratory and clinical medicine DO - 10.1016/j.trsl.2026.07.008 UR - https://doi.org/10.1016/j.trsl.2026.07.008 ER -
APA
X, T., X, M., E, S., X, L., W, F., H, H., Z, G., & B, G. (2026). From FLOW to translational positioning in chronic kidney disease: mechanistic complementarity of SGLT2 inhibitors and GLP-1 receptor agonists.. Translational research : the journal of laboratory and clinical medicine. https://doi.org/10.1016/j.trsl.2026.07.008
Source records
- pubmed · retrieved 2026-09-26T19:14:59.342Z